Nortian Peptide Sciences

Know exactly what’s
in the vial.

NPS compounds and dispenses its own peptides — prescribed by licensed U.S. providers, tested batch by batch, shipped from our own pharmacies.

  • Prescribed by licensed U.S. providers after a medical evaluation.
  • Compounded in licensed U.S. 503A pharmacies.
  • Every batch tested for identity, purity and potency.
  • We own the 503A pharmacies that compound your prescription.

Molecule → pharmacy → patient

Most telehealth brands buy their medicine.
We make ours.

Ro, Hims and Hers are distribution layers. NPS owns the pharmacy that compounds your prescription — and is building the American supply behind it.

  1. 01 From 2028

    Own the molecule

    Two Missouri API plants, coming online in 2028 and 2029, built for hybrid peptide synthesis.

  2. 02 Today

    Own the pharmacy

    Licensed 503A pharmacies we own outright, compounding every order to prescription.

  3. 03 Today

    Own the patient

    No middleman between the pharmacy and your door.

We are honest about the clock: today we own and operate the pharmacies and test every batch. Our own synthesis comes online in 2028.

The catalog

Six molecules. One standard.

Every one compounded to prescription in a pharmacy we own, and released against the same testing panel.

The anchor product

BPC-157.
Fifteen amino acids,
accounted for.

A 15-amino-acid peptide studied in the context of gastrointestinal tissue.

C6-BPC · 15 residues · subcutaneous

What a peptide is

Not a supplement. Not a biologic.
Something in between.

Peptides are short amino-acid chains of 2–50 residues, between 500 and 5,000 daltons — sitting between small molecules and biologics.

2–50 amino acid residues
Short enough to synthesize, long enough to be specific.
500–5,000 daltons
Between a small molecule and a biologic.
High receptor specificity
Binds its target with biologic precision.
SC self-administered
Subcutaneous — the kitchen counter, not the infusion suite.

Peptides are metabolized to amino acids — the body’s native building blocks — and are typically self-administered subcutaneously.

Co-Founding Partner

Gary Brecka didn’t endorse NPS.
He helped build it.

He carried specialty peptides from a biohacker niche into a mainstream health conversation. That is the demand curve NPS supplies — and he is aligned through founder equity, not a sponsorship fee.

  • Founder of The Ultimate Human, a top-ranked health & longevity platform
  • Co-founder of 10X Health
  • Creator of the Superhuman Protocol
  • 250M+ annual content views
  • 3M+ community across channels
  • 20 years of mortality and functional-medicine data

Gary Brecka is a co-founding partner of Nortian Peptide Sciences and holds an equity interest in the company.

In the community

People who take this seriously.

  • Andre M.Strength coach

    Illustrative example — not an actual patient

  • Priya N.Longevity writer

    Illustrative example — not an actual patient

  • Dominic R.Endurance athlete

    Illustrative example — not an actual patient

  • Yara S.Nutrition educator

    Illustrative example — not an actual patient

  • Beau T.Recovery specialist

    Illustrative example — not an actual patient

  • Ines V.Sleep researcher

    Illustrative example — not an actual patient

  • Marcus T.BPC-157 · 4 months
    The intake was thorough. A provider actually asked follow-up questions instead of rubber-stamping it.

    Illustrative example — not an actual patient

  • Helena K.BPC-157 · 6 months
    What sold me was the lot number on the vial matching a certificate I could actually read.

    Illustrative example — not an actual patient

  • Ravi P.BPC-157 · 3 months
    I had used gray-market vials before. The difference in labeling alone was worth the switch.

    Illustrative example — not an actual patient

The bench

Real science.
Named scientists.

Every claim we make has a person's name attached to it.

Meet the team
  • Victor Cioffi, PhD

    Molecular Biology & R&D

    • PhD, Microbiology — molecular biology
    • 6+ years of biotech R&D
    • Specialist in recombinant proteins, monoclonal antibodies and immunotherapy
  • Navdar Sever, PhD

    Lipid Biochemistry & Cell Signaling

    • PhD, UT Southwestern — trained under Nobel laureates Brown & Goldstein
    • 19 publications, 2,700+ citations
    • 15+ years in cholesterol metabolism and signaling
  • Kenneth Carter, PhD

    Board Advisor

    • Two NASDAQ IPOs founded and led
    • 30 years building biotech ventures
    • Former head of gene mapping at Human Genome Sciences
  • Duda Franklin

    Neuroscientist & Biomedical Engineer

    • MSc Neuroengineering; MSc Science, Technology & Innovation
    • Forbes 30 Under 30 honoree
    • Co-founder of Orby, a neurotech company

Reviewing clinicians

  • Dr. Elena R. Vance, MD

    Internal medicine · Florida

    Illustrative example — not an actual provider

  • Dr. Marcus D. Oyelaran, DO

    Sports medicine · Texas

    Illustrative example — not an actual provider

  • Dr. Priyanka S. Raghunath, MD

    Gastroenterology · Arizona

    Illustrative example — not an actual provider

  • Dr. Théo L. Brassard, MD

    Endocrinology · Nevada

    Illustrative example — not an actual provider

The Quality Charter

Four rules we don’t bend.

Capacity, channel and geography are replicable. Quality discipline is not.

  1. I

    Tier-1 API only

    Tier-1 API only — sourced from U.S. and allied producers, with auditable COA, chiral panel and residual-solvent data on every lot.

  2. II

    Per-batch release

    Per-batch release: LC-MS/MS identity, HPLC potency, LAL endotoxin, USP <71> sterility, USP <788> particulates. QP sign-off mandatory.

  3. III

    cGMP discipline

    cGMP discipline under 21 CFR §211 from day one — process validation, environmental monitoring, change control, deviation tracking.

  4. IV

    BIOSECURE-resilient

    BIOSECURE-resilient two-vendor sourcing, with vial-level serialization.

How it works

Four steps, no surprises.

  1. 1

    Take the quiz

    Two minutes. It includes a real safety screen, and a real not-eligible answer.

  2. 2

    A licensed provider reviews

    A U.S.-licensed provider evaluates your intake. Approval is not guaranteed.

  3. 3

    We compound and ship

    Your prescription is compounded to order in a 503A pharmacy we own.

  4. 4

    Ongoing care and refills

    Reorder, adjust, or stop. Your provider stays in the loop.